CFR Falls in Chile After Posting Profit Below Estimates

CFR Pharmaceuticals SA, Chile’s largest drug developer, fell the most in five months after reporting fourth-quarter earnings that were below some analysts’ expectations.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.